NewsHK
Against the backdrop of persistent shareholder litigation across U.S. equity markets, investor alerts have become a familiar precursor to securities class actions.
On July 16, 2026, New York-based Pomerantz LLP issued one such notice, announcing an investigation of claims on behalf of investors of NovoCure Limited (NASDAQ: NVCR), without specifying the nature of the underlying claims.
What the announcement says Pomerantz LLP has designated Danielle Peyton as the named contact for NovoCure investors.
Those who believe they may have claims can reach Peyton at newaction@pomlaw.com or by telephone at 646-581-9980, extension 7980. The announcement, issued from New York, names no NovoCure executives.
Keep reading